Posted: 02 Dec 2014 01:00 AM PST
Few
classes of drugs have had such a transformative effect on the
prevention of cardiovascular disease (CVD) as have statins, prescribed
to reduce total cholesterol and low-density lipoprotein cholesterol.
However, some clinicians have ongoing concerns regarding the potential
for lens opacities (cataracts) as a result of statin use. In an article
in the Canadian Journal of Cardiology, researchers report increased risk
for cataracts in patients treated with statins.
